Summary
In Alzheimer’s disease, which primarily involves memory disturbance, the neuropathological changes that occur may disrupt normal synaptic function. The presence of dystrophic nerve terminals associated with senile plaques in cortical areas involved with learning (especially the hippocampus and temporal neocortex) provides evidence of significant presynaptic disruption which increases with increasing plaque density. Such presynaptic abnormalities are reflected in the neurochemical deficits that occur in at least three extrinsic neurotransmitter systems in the cerebral cortex (cholinergic, noradrenergic and serotoninergic) in Alzheimer’s disease. The cholinergic deficit appears to be most closely correlated with the memory disturbance observed in both Alzheimer’s disease and Parkinson’s disease with dementia. Currently available evidence suggests that retrograde degeneration of the cortical cholinergic input may occur as a result of the neuropathological changes in Alzheimer’s disease, while in Parkinson’s disease with dementia where there are no marked neuropathological changes in the cortex, anterograde degeneration of the cholinergic system may occur. This focusses attention on the nature of senile plaques in relation to their ability to induce presynaptic dysfunction in Alzheimer’s disease. Elemental analysis shows that aluminium and silicon are present as aluminosilicates in the centre of plaque cores. Chemically active aluminosilicate species may be responsible for at least some of the presynaptic changes observed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Agid, Y., and Javoy Agid, F., 1985, Peptides and Parkinson’s disease, Trends Neurosci., 8: 30–35.
Allsop, D., Landon, M., and Kidd, M., 1983, Isolation and amino acid composition of senile plaque core protein, Brain Res, 259: 348–352.
Austin, JH., Rinehart, R., Williamson, RJ., Burcar, P., Russ, K., Nikaido, T., and Lafranee, M., Studies in ageing of the brain. III. Silicon levels in postmortem tissues and body fluids, in: “Progress in Brain Research,” DH. Ford, ed., 40:485–495, Elsevier, Amsterdam (1973).
Berger, B., Escourolle, R., and Moyne, M. A., 1976, Axones caticholaminergues du cortex cerebral humain, Rev Neurobiol., 136: 183–191.
Blessed, G., Tomlinson, B. E., and Roth, M. 1968, The association between quantitative measures of dementia and of senile change in the cerebral grety matter of elderly subjects, Brit. J. Psychiat., 114: 797–811.
Bullamore, J. R., Wilkinson, R., Gallagher, J. C., Nordin, B. E. C., and Marshall, D. H., 1970, Effect of age on calcium absorption, Lancet, 2: 535–537.
Burks, J. S., Alfrey, A. C., Huddlestone, J., Norenberg, M. D., and Lewin, E., 1976, A fatal encephalopathy in chronic haemodialysis patients, Lancet, 1: 764–768.
Candy, JM., Oakley, AE., Perry, RH., Perry, EK., and Edwardson, JA., New observations on the nature of the senile plaque, in: “Regulation of transmitter function,” ES Vizi, and K. Magyar, eds., pp301–306, Academia, Kiado (1984).
Candy, J. M., Perry, R. H., Perry, E. K., Irving, D., Blessed, G., Fairbairn, A. F., and Tomlinson, B. E., 1983, Pathological changes in the nucleus of Meynert in Alzheimer’s and Parkinson’s diseases, J. Neurol. Sci., 54: 277–289.
Crapper, DR ., Functional consequences of neurofibrillary degeneration, in: “Neurobiology of Aging,” RD. Terry, and S, Gershon, eds., pp405–432, Raven Press, New York (1976).
Crapper, D. R., Krishman, S. S., and Dalton, A. J., 1973, Brain aluminium distribution in Alzheimer’s disease and experimental neurofibrillary degeneration, Science, 180: 511–513.
Crapper, D. R., Krishman, S. S., and Quittkat, S., 1976, Aluminium neurofibrillary degeneration and Alzheimer’s disease, Brain, 99: 67–80.
Cross, A. J., Crow, T. J., Ferrier, I. N., Johnson, A., Bloom, S. R., and Corsellis, J. A. N., 1984, Serotonin receptor changes in dementia of the Alzheimer type, J. Neurochem., 43: 1574–1581.
Duckett, S., and Galle, P., 1976, Mise en evidence de l’aluminium dans les plaques seniles de la maladie d’Alzheimer: etude de la microsonde de castaing, C.R. Acad. Sci. (Paris), 282: 393–395.
Duckett, S., and Galle, P., 1980, Electron microscope microprobe studies of aluminium in the brains of cases of Alzheimer’s disease and ageing patients, J. Neuropath. Exp. Neurol., 39: 350 (Abst.).
Garruto, R. M., Fukatsu, R., Yanagihara, R., Gajdusek, D. C., Hook, G., and Fiori, C. E., 1984, Imaging of calcium and aluminium in neurofibrillary tangle bearing neurones in Parkinsonism - dementia of Guam, Proc. Natl. Acad. Sci. USA, 81: 1875–1870.
Gulya, K., Watson, M., Vickroy, TW., Rocske, WR., Perry, RH., Perry, EK., Duckies, SP., Wamsley, JK., Gehlert, D., and Yamamura, HI., 1985, Examination of cholinergic and neuropeptide receptor alterations in Alzheimer’s disease (SDAT), Abstracts, Oholo Biological Conference.
Kitt, C. A., Price, D.L., Struble, R. G., Cork, L. C., Wainer, B. H., Becher, M. W., and Mobley, W. C., 1984, Evidence for cholinergic neurites in senile plaques, Science, 226: 1443–1444.
Klatzo, I., Wisniewski, H. M., and Streiker, E., 1965, Experimental production of neurofibrillary degeneration. I. Light microscopic observations, J. Neuropath. Exp. Neurol., 24: 187–199.
Marinesco, G ., 1928, Recherches sur les plaques seniles, Bull. Sect. Scient de l’Acad roumaine, 7:1.
Markesbery, W. R., Ehmann, W. D., Hassain, T. I. M., Alauddin, M., and Goodin, D. T., 1981, Instrumental neutron activation analysis of brain aluminium in Alzheimer’s disease and aging, Arch. Neurol., 10: 512–516.
Markesbery, W. R., Ehmann, W. D., Hassain, T. I. M., Alauddin, M., and Goodin, D. T., 1981, Instrumental neutron activation analysis of brain aluminium in Alzheimer’s disease and aging, Arch. Neurol., 10: 512–516.
McDermott, J. R., Smith, A. I., Iqbal, K., and Wisniewski, H. M., 1979, Brain aluminium in aging and Alzheimer’s disease, Neurology, 29: 809–814.
Morrison, J. H., Rogers, J., Scherr, S., Benoit, R., and Bloom, F. E., 1985, Somatostatin immunoreactivity in neuritic plaques in Alzheimer’s patients, Nature, 314: 90–92.
Nikaido, T., Austin, J., Trueb, L., and Rinehart, R., 1972, Studies in ageing of the brain. II. Microchemical analyses of the nervous system in Alzheimer patients, Arch. Neurol, 27: 549–554.
Palacios, J. M., 1982, Autoradiographic localization of muscarinic cholinergic receptors in the hippocampus of patients with senile dementia, Brain Res, 243: 173–178.
Pearce, B. R., Palmer, A. M., Bowen, D. M., Wilcock, G. JC., Esiri, M. M., and Davison, A. N., 1984, Neurotransmitter dysfunction and atrophy of the caudate nucleus in Alzheimer’s disease, Neurochemical Pathology, 221–232.
Pearson, R. C. A., Sofroniew, M. V., Cuello, A. C., Powell, T. P. S., Eckenstein, F., Esiri, M. M., and Wilcock, G. K., 1983, Persistence of cholinergic neurones in the basal nucleus in a brain with senile dementia of Alzheimer type demonstrated by immunohistochemical staining for choline acetyltransferase, Brain Res, 289: 375–379.
Pendlebury, W. W., and Perl, D. P., 1984, Nucleus basalis of Meynert: severe cell loss in Parkinson’s disease without dementia, Ann Neurol, 16: 63.
Perl, D. P., and Brody, A. R., 1980, Alzheimer’s disease: X-ray spectrometric evidence of aluminium accumulation in neurofibrillary tangle-bearing neurones, Science, 208: 297–299.
Perl, D. P., Gajdusek, D. C., Garruto, R. M., Yanagihara, R. T., and Gibbs, C. J., 1982, Intraneuronal aluminium accumulation in amyotrophic lateral sclerosis and Parkinsonism - dementia of Guam, Science, 217: 1053–1055.
Perry, RH ., Neuropathology of dementia, in: “Dementia, a clinical approach,” JMS Pearce, ed., pp89–116, Blackwell Scientific Publications, Oxford (1984).
Perry, RH., Blessed, G., Perry, EK., and Tomlinson, BE., 1980, Histochemical observations on cholinesterase activities in the brains of elderly normal and demented (Alzheimer type) patients, Age and Aging, 9:9–16.
Perry, RH., Candy, JM., and Perry, EK., Some observations and speculations concerning the cholinergic system and neuropeptides in Alzheimer’s disease, in: “Banbury Report 15: Biological aspects of Alzheimer’s disease,” RD Terry, and R. Katzman, eds., pp351–361, Cold Spring Laboratory, New York (1983a).
Perry R. H., Candy, J. M., Perry, E. K., Irving, D., Blessed, G., Fairbairn, A. F., and Tomlinson, B. E., 1982, Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer’s disease, Neurosci. Lett., 33: 311–315.
Perry R. H., Candy, J. M., Perry, E. K., Irving, D., Blessed, G., Fairbairn, A. F., and Tomlinson, B. E., 1982, Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer’s disease, Neurosci. Lett., 33: 311–315.
Perry, E. K., Perry, R. H., Candy, J. M., Fairbairn, A. F., Blessed, G., Dick, D. J., and Tomlinson, B. E., 1984, Cortical serotonin-S2 receptor binding abnormalities in Alzheimer’s disease: comparisons with Parkinson’s disease, Neuosci. Lett., 51: 353–357.
Perry, R. H., Tomlinson, B. E., Candy, J. M., Blessed, G., Foster, J. F., Bloxham, C. A., and Perry, E. K., 1983b, Cortical cholinergic deficit in mentally impaired Parkinsonian patients, Lancet, 2: 789–790.
Petit, T. L., Biederman, G. B., and McMullen, P. A., 1980, Neurofibrillary degeneration, dendritic dying back and learning memory deficits after aluminium administration: implications for brain aging, Exp. Neurol., 67: 152–162.
Probst, A., Baster, V., Bron, B., and Ulrich, J., 1983, Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region, Brain Res, 268: 249–254.
Roberts, G. W., Crow, T. J., and Polak, J. M., 1985, Location of neuronal tangles in somatostatin neurones in Alzheimer’s disease, Nature, 314: 92–94.
Rudelli, R. D., Ambler, M. W., and Wisniewski, H. M., 1984, Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalin, Acta Neuropath, 64: 273–281.
Struble, R. G., Cork, L. C., Whitehouse, P. J., and Price, D. L., 1982, Cholinergic innervation in neuritic plaques, Science, 216: 413–415.
Struble, R. G., Hedreen, J. C., Cork, L. C. and Price, D. L., 1984, Acetylcholinesterase activity in senile plaques of aged macaques, Neurobiol. Aging, 5: 191–198.
Terry, R. D., and Pena, C., 1965, Experimental production of neurofibrillary degeneration. 2. Electronmicroscopy, phosphatase histochemistry and electron probe microanalysis, J. Neuropath. Exp. Neurol., 24: 200–210.
Tomlinson, B. E., 1982, Plauqes, tangles and Alzheimer’s disease, Psychol. Medicine, 12: 449 - 459.
Traub, R. D., Rains, T. C., Garruto, R. M., Gajdusek, D. C., and Gibbs, C. J., 1981, Brain distruction alone does not elevate brain aluminium, Neurology, 31: 986–989.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Edwardson, J., Perry, R., Candy, J., Oakley, A., Perry, E. (1986). Structural and Chemical Aspects of Cortical Pathology in Alzheimer’s Disease. In: Fisher, A., Hanin, I., Lachman, C. (eds) Alzheimer’s and Parkinson’s Disease. Advances in Behavioral Biology, vol 29. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2179-8_6
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2179-8_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9283-8
Online ISBN: 978-1-4613-2179-8
eBook Packages: Springer Book Archive